Clinic
Keowee Primary Care & Internal Medicine PC
Keowee Primary Care & Internal Medicine PC was paid $1.97M by Medicaid between Jan 2018 and Nov 2024, across 97 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoKEOWEE PRIMARY CARE & INTERNAL MEDICINE PC
SENECA, SC 29678
SENECA, SC 29678
33aNPI1548371222assigned 08/31/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.97M
24GClaims84,307
24DCodes billed97
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in South Carolina
Rank by total paid#12 of 36
Median peer was paid$695K
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,558 | $505K | |
| 2019 | 11,403 | $299K | |
| 2020 | 11,152 | $307K | |
| 2021 | 14,355 | $392K | |
| 2022 | 11,521 | $248K | |
| 2023 | 9,522 | $138K | |
| 2024incomplete | 6,796 | $82K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 14,614 | 11,501 | $618K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 8,578 | 5,993 | $358K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 3,037 | 2,619 | $239K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.2% | 750 | 693 | $63K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.2% | 964 | 801 | $62K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 1,452 | 1,252 | $62K |
| 93880 | 2.3% | 892 | 729 | $46K | |
| 83880 | 1.9% | 1,310 | 1,154 | $37K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 703 | 604 | $28K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 1,111 | 1,040 | $27K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 694 | 646 | $23K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 499 | 332 | $22K |
85 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,565 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 2,968 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,558 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,664 | $19K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,958 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,105 | $16K |
| 82607 | <1% | 1,112 | $15K | |
| 82746 | <1% | 1,113 | $14K | |
| 80061 | Lipid panel | <1% | 1,464 | $14K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 139 | $14K |
| 93000 | <1% | 2,182 | $14K | |
| 87503 | <1% | 611 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 701 | $13K |
| 94060 | <1% | 660 | $11K | |
| 80076 | <1% | 1,563 | $10K | |
| 84439 | <1% | 1,550 | $10K | |
| 83525 | <1% | 1,046 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,207 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,409 | $7K |
| 83735 | <1% | 1,057 | $6K | |
| 95923 | <1% | 301 | $5K | |
| 80305 | <1% | 454 | $5K | |
| 94375 | <1% | 298 | $5K | |
| 95115 | <1% | 1,318 | $5K | |
| 81001 | <1% | 1,439 | $4K | |
| 82668 | <1% | 232 | $4K | |
| 20611 | <1% | 82 | $4K | |
| 82728 | <1% | 360 | $4K | |
| 94200 | <1% | 409 | $4K | |
| 94729 | <1% | 346 | $4K | |
| 72100 | <1% | 266 | $4K | |
| 93922 | <1% | 268 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 98 | $3K |
| 85651 | <1% | 1,109 | $3K | |
| 94726 | <1% | 303 | $3K | |
| 83550 | <1% | 344 | $3K | |
| 95943 | <1% | 58 | $3K | |
| 86141 | <1% | 252 | $3K | |
| 83540 | <1% | 403 | $2K | |
| 73560 | <1% | 182 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 275 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $2K |
| 83090 | <1% | 108 | $2K | |
| 82962 | <1% | 2,057 | $2K | |
| 82172 | <1% | 205 | $2K | |
| 81003 | <1% | 1,073 | $2K | |
| 95921 | <1% | 200 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,706 | $2K |
| 90674 | <1% | 91 | $2K | |
| 83695 | <1% | 114 | $2K | |
| 93923 | <1% | 30 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 78 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 163 | $1K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 33 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 393 | $1K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 93 | $964.89 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 103 | $907.79 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 67 | $868.05 |
| 93015 | <1% | 47 | $839.51 | |
| 76536 | <1% | 13 | $787.33 | |
| 73521 | <1% | 41 | $665.23 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 25 | $631.02 |
| 82239 | <1% | 30 | $585.90 | |
| 96127 | <1% | 145 | $437.88 | |
| 90688 | <1% | 64 | $384.12 | |
| 84550 | <1% | 73 | $334.32 | |
| 82150 | <1% | 77 | $331.85 | |
| 95117 | <1% | 38 | $269.18 | |
| 83690 | <1% | 66 | $248.22 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 18 | $189.36 |
| 90756 | <1% | 33 | $186.92 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 106 | $124.79 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 19 | $22.88 |
| 36416 | <1% | 225 | $11.65 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 141 | $8.33 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 183 | $0.32 |
| 3079F | 0% | 88 | $0.00 | |
| 3044F | 0% | 173 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 30 | $0.00 |
| 3074F | 0% | 156 | $0.00 | |
| 4010F | 0% | 27 | $0.00 | |
| 3075F | 0% | 20 | $0.00 | |
| 1159F | 0% | 430 | $0.00 | |
| 1160F | 0% | 405 | $0.00 | |
| 3078F | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEYLON, TRACY (OFFICE MANAGER)